in this study, we investigated role and results of multi-reoperations for lung metastases. from 1986 to 2010, 113 consecutive patients (61 men and 52 women; mean age: 53.2 +/- 12.8 years) underwent repeated lung metastasectomy with curative intent in our institution. two procedures were performed in 113 patients, three in 54, four in 31, five in eight and six in three. there was no perioperative mortality. cumulative 5-year survival was 65% and this was significantly higher than the value recorded for patients undergoing only one metastasectomy (42%; p = 0.021). size, number of resections and probability of recurrence increased by number of operation whereas disease free interval reduced. at any metastasectomy both short disease-free interval and multiple metastases resulted in the most significant negative prognosticators. in conclusion, redo metastasectomy is worthwhile for the initial procedures, afterwards both disease-free and overall survivals decrease and surgery lose its efficacy.
Mineo, T.c., Ambrogi, V., Tacconi, F., Mineo, D. (2015). Multi-reoperations for lung metastases. FUTURE ONCOLOGY, 11(2s), 37-41 [10.2217/fon.14.282].
Multi-reoperations for lung metastases
Mineo, T. C.;Ambrogi, V.;Tacconi, F.;Mineo, D.
2015-01-01
Abstract
in this study, we investigated role and results of multi-reoperations for lung metastases. from 1986 to 2010, 113 consecutive patients (61 men and 52 women; mean age: 53.2 +/- 12.8 years) underwent repeated lung metastasectomy with curative intent in our institution. two procedures were performed in 113 patients, three in 54, four in 31, five in eight and six in three. there was no perioperative mortality. cumulative 5-year survival was 65% and this was significantly higher than the value recorded for patients undergoing only one metastasectomy (42%; p = 0.021). size, number of resections and probability of recurrence increased by number of operation whereas disease free interval reduced. at any metastasectomy both short disease-free interval and multiple metastases resulted in the most significant negative prognosticators. in conclusion, redo metastasectomy is worthwhile for the initial procedures, afterwards both disease-free and overall survivals decrease and surgery lose its efficacy.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.